These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3318954)

  • 1. [Study of the participation of the alpha-chain of the LFA-1 antigen in the phenomenon of lymphocyte adherence inhibition using ICO-11 monoclonal antibodies in vitro].
    Kharkevich DD; Baryshnikov AIu; Savel'eva EV; Polevaia EB; Kadagidze ZG
    Biull Eksp Biol Med; 1987 Dec; 104(12):711-3. PubMed ID: 3318954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monoclonal antibodies against the alpha-chain of human lymphocyte function-associated antigen-1].
    Baryshnikov AIu; Dubinkin IV; Savel'eva EV; Veskova TK; Tupitsyn NN
    Biull Eksp Biol Med; 1988 Jan; 105(1):55-8. PubMed ID: 3276359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T8 and T3 surface glycoproteins in human T-cell mediation of leukocyte adherence inhibition to extracts of autologous cancer.
    Labateya N; Thomson DM
    J Natl Cancer Inst; 1985 Dec; 75(6):987-94. PubMed ID: 2999497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking of the response by human T-lymphocytes to extracts of autologous cancer by monoclonal antibody to Class-I major histocompatibility complex gene products in the leukocyte adherence inhibition assay.
    Shenouda G; Thomson DM
    Cancer Res; 1984 Jul; 44(7):2762-8. PubMed ID: 6609766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
    Tsang PH; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement for autologous cancer extracts and lipoxygenation of arachidonic acid for human T-cell responses in leukocyte adherence inhibition and transmembrane potential change assays.
    Shenouda G; Thomson DM; MacFarlane JK
    Cancer Res; 1984 Mar; 44(3):1238-45. PubMed ID: 6420056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms, kinetics and specificity of the leukocyte adherence inhibition test in breast cancer].
    Kharkevich DD; Polevaia EB; Derevnina NA; Sablikova IuA; Savinov AIu
    Eksp Onkol; 1985; 7(6):69-73. PubMed ID: 3910405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
    Okada Y
    Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Micromodification of the leukocyte adherence inhibition test for cancer patients].
    Kharkevich DD; Tabagari DZ; Savinov AIu
    Vopr Onkol; 1985; 31(7):17-21. PubMed ID: 3895734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte adherence inhibition responses obtained with various tumor extracts in breast cancer patients.
    Kovarík J; Lauerová L; Feit J; Ninger E; Munzarová M; Zemanová D; Hlávková J
    Cancer Detect Prev; 1983; 6(1-2):215-9. PubMed ID: 6349799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that leukocyte function-associated antigen-1 is involved in recirculation and homing of human lymphocytes via high endothelial venules.
    Pals ST; den Otter A; Miedema F; Kabel P; Keizer GD; Scheper RJ; Meijer CJ
    J Immunol; 1988 Mar; 140(6):1851-3. PubMed ID: 3279123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
    Kotlar HK; Sanner T
    J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1.
    Watabe D; Kanno H; Yoshida A; Kurose A; Akasaka T; Sawai T
    Br J Dermatol; 2007 Aug; 157(2):259-65. PubMed ID: 17596165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the LFA-1 molecule in cellular interactions required for antibody production in humans.
    Fischer A; Durandy A; Sterkers G; Griscelli C
    J Immunol; 1986 May; 136(9):3198-203. PubMed ID: 3514755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the mechanism of the leukocyte adherence inhibition test.
    Tong AW; Burger DR; Finke P; Barney C; Vandenbark AA; Vetto RM
    Cancer Res; 1979 Feb; 39(2 Pt 2):597-603. PubMed ID: 367586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and Lyt-2, 3. II. Evidence that trypsin pretreatment of target cells removes a non-H-2 molecule important in killing.
    Gromkowski SH; Heagy W; Martz E
    J Immunol; 1985 Jan; 134(1):70-7. PubMed ID: 3880579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of autoimmune diabetes by treatment with anti-LFA-1 and anti-ICAM-1 monoclonal antibodies.
    Herold KC; Vezys V; Gage A; Montag AG
    Cell Immunol; 1994 Sep; 157(2):489-500. PubMed ID: 7915204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
    Ludwig HJ; Storch H
    Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in sensitivity of lymphocyte cholinergic receptors in patients with breast cancer].
    Kharkevich DD; Polevaia EB
    Eksp Onkol; 1988; 10(5):38-40. PubMed ID: 2905257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heritable lymphocyte function-associated antigen-1 deficiency: abnormalities of cytotoxicity and proliferation associated with abnormal expression of LFA-1.
    Krensky AM; Mentzer SJ; Clayberger C; Anderson DC; Schmalstieg FC; Burakoff SJ; Springer TA
    J Immunol; 1985 Nov; 135(5):3102-8. PubMed ID: 3900204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.